malignancy body involved cancers typically found body defining cancer body genes prying treatment options loose old restrictions drug conventionally cancer turn work driven abnormality drugs trastuzumab lapatinib approved breast cancer harboring mutation given group patients late stage colorectal cancer mutation example nearly half lived year unusually long time connections rare preliminary indicate time reconsider standard definitions cancer nci launched new collaborations called match august 2015 study expects enroll 840 volunteers aims provide data needed doctors prescribe drugs patients based tumor genetics dna 5,000 tumor specimens sequenced find suspicious abnormalities matching gene targeted drugs trial started eligible patients received 10 gene